[Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Presse medicale

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lpm.2015.07.003PMID 26278157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.

  2015cited by this paper
• Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial

  2015cited by this paper
• Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.

  2015cited by this paper
• Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future

  2013cited by this paper
• Tissue-selective estrogen complexes for postmenopausal women.

  2013cited by this paper
• Evolution of the tissue selective estrogen complex (TSEC)

  2013cited by this paper
• Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α.

  2012cited by this paper
• Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens

  2012cited by this paper
• The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1

  2011cited by this paper
• Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?

  2011cited by this paper
• Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study

  2010cited by this paper
• Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

  2010cited by this paper
• Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism: Results From the E3N Cohort Study

  2010cited by this paper
• Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.

  2010cited by this paper
• Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.

  2009cited by this paper
• Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.

  2009cited by this paper
• Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

  2008cited by this paper
• Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study

  2007cited by this paper
• Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

  2007cited by this paper
• Pharmacology of estrogens and progestogens: influence of different routes of administration

  2005cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Estrogen replacement therapy, atherosclerosis, and vascular function.

  2002cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

  1991cited by this paper

• Synthesis and Computational Studies of Novel Manganese Paracetamol Complexes: Insights from DFT and Docking Approaches for Reduced Hepatotoxicity and Enhanced Bioactivity

  2025cites this paper